Discounted Cash Flow Rating

Strong Sell

Return on Equity Rating

Strong Buy

Debt to Equity Rating

Strong Sell

Price to Earnings Rating

Strong Sell

Analyst Rating

Sell

Simple Moving Average

Buy

Exponential Moving Average

Buy

Relative Strength Index

Neutral

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Neutral

Insider Trading

Strong Buy

Wall Street Data Solutions Rating

Neutral

B

NRX Pharmaceuticals, Inc. Common Stock (NRXP)

Pharmaceutical Preparations

https://nrxpharma.com

NRX Pharmaceuticals Inc is a clinical-stage, small molecule pharmaceutical company which develops novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. It is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behaviour.

1201 ORANGE STREET, SUITE 600
WILMINGTON, DE

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

05/25/2021

Market Cap

18,940,078

Shares Outstanding

85,170,000

Weighted SO

85,167,479

Total Employees

N/A

Upcoming Earnings

08/12/2024

Beta

1.2600

Last Div

0.0000

Range

1.73-7.33

Chg

0.0300

Avg Vol

98043

Mkt Cap

18940078

Exch

NASDAQ

Country

US

Phone

484 254 6134

DCF Diff

2.3427

DCF

-0.6027

Div Yield

0.0000

P/S

2367.5098

EV Multiple

-1.1080

P/FV

-1.0122

Div Yield %

0.0000

P/E

-0.7501

PEG

0.0012

Payout

0.0000

Current Ratio

0.2063

Quick Ratio

0.2063

Cash Ratio

0.0802

DSO

273.7500

DIO

0.0000

Op Cycle

273.7500

DPO

366095.0000

CCC

-365821.2500

Gross Margin

0.3750

Op Margin

-2907.7500

Pretax Margin

-3102.3750

Net Margin

-3102.3750

Eff Tax Rate

0.0563

ROA

-4.7149

ROE

1.9311

ROCE

1.2649

NI/EBT

1.0000

EBT/EBIT

1.0669

EBIT/Rev

-2907.7500

Debt Ratio

1.6326

D/E

-0.4673

LT Debt/Cap

0.0000

Total Debt/Cap

-0.8772

Int Coverage

-66.4629

CF/Debt

-1.7375

Equity Multi

-0.2862

Rec Turnover

1.3333

Pay Turnover

0.0010

Inv Turnover

0.0000

FA Turnover

0.0000

Asset Turnover

0.0015

OCF/Share

-1.4197

FCF/Share

-1.4195

Cash/Share

0.1805

OCF/Sales

-1866.5000

FCF/OCF

0.9999

CF Coverage

-1.7375

ST Coverage

-1.7375

CapEx Coverage

-7466.0000

Div&CapEx Cov

-7466.0000

P/BV

-1.0122

P/B

-1.0122

P/S

2367.5098

P/E

-0.7501

P/FCF

-1.2686

P/OCF

-1.2467

P/CF

-1.2467

PEG

0.0012

P/S

2367.5098

EV Multiple

-1.1080

P/FV

-1.0122

DPS

0.0000

Latest Headlines (EST)

Revenue Product Segmentation